Jagannadha Avasarala

13PUBLICATIONS
1CO-AUTHORS
Medical infection agents (incl. prions)Pacific Peoples health and wellbeing not elsewhere classifiedComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Neurology and neuromuscular diseasesPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 17, 2025
JC virus PCR assay reporting for PML: promises, perils, and pitfalls.

Jagannadha Avasarala, Suhas Gangadhara

|Aug 22, 2023
Unmasking disparities: the challenge of diversity, equity, and inclusion in Press Ganey surveys.

Jagannadha Avasarala, Phenu Zachariah

|May 23, 2022
VAERS-reported new-onset seizures following use of COVID-19 vaccinations as compared to influenza vaccinations.

Jagannadha Avasarala, Christopher J McLouth, Luther C Pettigrew

|Feb 10, 2021
Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: when will we achieve parity?

Jagannadha Avasarala, Phenu Zachariah, Breck Turner

|Jul 16, 2019
Radiologically isolated syndrome is antiquated amidst evolving McDonald criteria for multiple sclerosis.

Jagannadha Avasarala, Fawad Yousuf

|Jan 04, 2019
FDA-approved drugs for multiple sclerosis have no efficacy or disability data in non-Caucasian patients.

Jagannadha Avasarala

Pageof 3

Frequent Collaborators

1 joint publications

Suresh Keshavamurthy